9 results
424B3
PNT
POINT Biopharma Global Inc.
31 Mar 22
Prospectus supplement
11:42am
of the PIPE Financing and the proceeds remaining in RACA’s trust account. We intend to use the net proceeds from these transactions for general corporate … purpose, funding of development programs, payment of milestones pursuant to our license agreements, general and administrative expenses, licensing
POS AM
PNT
POINT Biopharma Global Inc.
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
intend to use the net proceeds from these transactions for general corporate purpose, funding of development programs, payment of milestones pursuant
424B3
PNT
POINT Biopharma Global Inc.
12 Nov 21
Prospectus supplement
8:41am
Inc. were exercised resulting in net proceeds of $20,000,000. We intend to use the net proceeds from the transaction for general corporate purpose, funding
424B3
src nol5qc
13 Aug 21
Prospectus supplement
5:25pm
424B3
es1fydy
5 Aug 21
Prospectus supplement
4:26pm
- Prev
- 1
- Next